Drug profile · INN
diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed)
TRIACELLUVAX
diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed) (TRIACELLUVAX) is an FDA-listed pharmaceutical active ingredient.
EMA: withdrawn Antiinfectives for systemic use (J07) J07AJ
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed) (TRIACELLUVAX) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed)
Brand TRIACELLUVAX
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07AJ
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed)?
diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed) (TRIACELLUVAX) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed)?
TRIACELLUVAX is a marketed brand name for diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.